SCHEMBL24604393

SCHEMBL24604393

c1ccc([Si](c2ccccc2)(c2ccccc2)c2cccc(-c3nc(-c4cccc([Si](c5ccccc5)(c5ccccc5)c5ccccc5)c4)nc(-c4cccc([Si](c5ccccc5)(c5ccccc5)c5ccccc5)c4)n3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 8/20 0.44
KMT2A Q03164 8/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPT P10636 4/20 0.44
HPGD P15428 4/20 0.44
LMNA P02545 3/20 0.44
KDM4E B2RXH2 2/20 0.44
GLA P06280 1/20 0.41
ADORA2A P29274 2/20 0.40
ADORA1 P30542 2/20 0.40
POLB P06746 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2B P29275 1/20 0.40
RAB9A P51151 4/20 0.39
NTSR1 P30989 1/20 0.38
NPC1 O15118 2/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 2/20 0.36
GP6 Q9HCN6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20655518 0.98 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL24604422 0.98 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL30826299 0.98 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23268359 0.98 L3MBTL1 (0.43) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL21340666 0.98 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23268516 0.96 MEN1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23268105 0.96 L3MBTL1 (0.47) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23268103 0.96 MEN1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23268205 0.96 L3MBTL1 (0.47) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23268138 0.96 L3MBTL1 (0.42) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230141905-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-11 US disclosed
US-20230141905-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-11 US disclosed
US-20230129565-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed
US-20230129565-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed
US-20220216434-A1 LIGHT-EMITTING DEVICE AND AN ELECTRONIC APPARATUS COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230129565-A1 ORGANIC ELECTROLUMINESCENCE DEVICE MAL2, SLC39A14, SLC39A3 L3MBTL1 432/4885MEN1 1684/4885KMT2A 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.